The University of Chicago Header Logo

Connection

Walter M. Stadler to Lymphopenia

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Lymphopenia.
Walter M. Stadler
Connection Strength
0.021
Lymphopenia
  1. A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study. Anticancer Drugs. 2009 Mar; 20(3):179-84.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.